{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:17:41Z","timestamp":1792279061527,"version":"4.4.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.tips.2021.11.015","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T02:30:55Z","timestamp":1642213855000},"page":"641-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":215,"title":["Progranulin as a therapeutic target in neurodegenerative diseases"],"prefix":"10.1016","volume":"43","author":[{"given":"Herve","family":"Rhinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Tatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"McCaughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kurnellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1885-3880","authenticated-orcid":false,"given":"Arnon","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.11.015_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-8559-3_1","article-title":"A brief overview of progranulin in health and disease","volume":"1806","author":"Bateman","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tips.2021.11.015_bb0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1083\/jcb.201603079","article-title":"EphA2 is a functional receptor for the growth factor progranulin","volume":"215","author":"Neill","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2021.11.015_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2019.01.002","article-title":"Progranulin: a conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases","volume":"45","author":"Cui","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.tips.2021.11.015_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1083\/jcb.200712039","article-title":"Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival","volume":"181","author":"Van Damme","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2021.11.015_bb0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainres.2012.01.047","article-title":"Progranulin: an emerging target for FTLD therapies","volume":"1462","author":"Gass","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2021.11.015_bb0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","article-title":"Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin","volume":"68","author":"Hu","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2021.11.015_bb0035","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1083\/jcb.201502029","article-title":"Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin","volume":"210","author":"Zhou","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2021.11.015_bb0040","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jmb.2019.01.027","article-title":"Progranulin stimulates the in vitro maturation of pro-cathepsin D at acidic pH","volume":"431","author":"Butler","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tips.2021.11.015_bb0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.braindev.2019.03.004","article-title":"Neuronal ceroid lipofuscinosis type-11 in an adolescent","volume":"41","author":"Kamate","year":"2019","journal-title":"Brain and Development"},{"key":"10.1016\/j.tips.2021.11.015_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2021.11.015_bb0055","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","article-title":"Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses","volume":"1832","author":"Warrier","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2021.11.015_bb0060","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.11.015_bb0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40291-018-0347-7","article-title":"Alzheimer's disease and frontotemporal dementia: the current state of genetics and genetic testing since the advent of next-generation sequencing","volume":"22","author":"Goldman","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.tips.2021.11.015_bb0070","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1212\/WNL.0000000000004494","article-title":"Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis","volume":"89","author":"Curtis","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2021.11.015_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1262\/jrd.20249","article-title":"Roles of progranulin in sexual differentiation of the developing brain and adult neurogenesis","volume":"55","author":"Suzuki","year":"2009","journal-title":"J. Reprod. Dev."},{"key":"10.1016\/j.tips.2021.11.015_bb0080","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nature05017","article-title":"Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21","volume":"442","author":"Cruts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.11.015_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-007-0223-8","article-title":"The neuropathology and clinical phenotype of FTD with progranulin mutations","volume":"114","author":"Mackenzie","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2021.11.015_bb0090","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tips.2021.11.015_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5642","article-title":"Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis","volume":"9","author":"Ward","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2021.11.015_bb0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","article-title":"Genetics of Alzheimer's disease: where we are, and where we are going","volume":"61","author":"Bellenguez","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.tips.2021.11.015_bb0105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.tips.2021.11.015_bb0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1326-9-38","article-title":"Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene","volume":"9","author":"van Blitterswijk","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2021.11.015_bb0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.wnl.0000289191.54852.75","article-title":"Progranulin genetic variability contributes to amyotrophic lateral sclerosis","volume":"71","author":"Sleegers","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2021.11.015_bb0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cels.2017.02.009","article-title":"Differential aging analysis in human cerebral cortex identifies variants in TMEM106B and GRN that regulate aging phenotypes","volume":"4","author":"Rhinn","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.tips.2021.11.015_bb0125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/WAD.0b013e31820f8f50","article-title":"Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically","volume":"25","author":"Pao","year":"2011","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.tips.2021.11.015_bb0130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2021.11.015_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","article-title":"Association between progranulin and Gaucher disease","volume":"11","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tips.2021.11.015_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134873","article-title":"Reduced plasma progranulin levels are associated with the severity of Parkinson\u2019s disease","volume":"725","author":"Yao","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2021.11.015_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1742-2094-8-111","article-title":"Low plasma progranulin levels in children with autism","volume":"8","author":"Al-Ayadhi","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2021.11.015_bb0150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-006-0138-9","article-title":"Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype","volume":"112","author":"Mackenzie","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2021.11.015_bb0155","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2021.11.015_bb0160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.11.015_bb0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","article-title":"Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies","volume":"1184","author":"Higashi","year":"2007","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.tips.2021.11.015_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.14327","article-title":"Pathomechanisms of TDP-43 in neurodegeneration","volume":"146","author":"Gao","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2021.11.015_bb0175","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2019.03.014","article-title":"Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions","volume":"102","author":"Nussbacher","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2021.11.015_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biocel.2016.07.019","article-title":"The ubiquitin-proteasome system and autophagy: Coordinated and independent activities","volume":"79","author":"Cohen-Kaplan","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tips.2021.11.015_bb0185","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/jnr.23081","article-title":"p62\/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions","volume":"90","author":"Tanji","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tips.2021.11.015_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013368","article-title":"Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy","volume":"5","author":"Laird","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.11.015_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-018-0288-y","article-title":"Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice","volume":"13","author":"Beel","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2021.11.015_bb0200","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1084\/jem.20160999","article-title":"Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation","volume":"214","author":"Chang","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2021.11.015_bb0205","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2709-7","article-title":"Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency","volume":"588","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.11.015_bb0210","doi-asserted-by":"crossref","first-page":"10530","DOI":"10.1523\/JNEUROSCI.3421-07.2007","article-title":"Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.11.015_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12974-017-1000-9","article-title":"Selective depletion of microglial progranulin in mice is not sufficient to cause neuronal ceroid lipofuscinosis or neuroinflammation","volume":"14","author":"Petkau","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2021.11.015_bb0220","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/awx060","article-title":"Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia","volume":"140","author":"Arrant","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.tips.2021.11.015_bb0225","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.11.015_bb0230","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","article-title":"Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation","volume":"165","author":"Lui","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.11.015_bb0235","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3672","article-title":"Progranulin protects against amyloid beta deposition and toxicity in Alzheimer's disease mouse models","volume":"20","author":"Minami","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2021.11.015_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109581","article-title":"Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD","volume":"36","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.11.015_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2012.11.032","article-title":"Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient mice","volume":"231","author":"Tanaka","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2021.11.015_bb0250","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2021.11.015_bb0255","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.11.015_bb0260","doi-asserted-by":"crossref","first-page":"13741","DOI":"10.1038\/s41598-020-70687-7","article-title":"Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation","volume":"10","author":"Katzeff","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.11.015_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026454","article-title":"Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins","volume":"6","author":"Almeida","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.11.015_bb0270","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/glia.23091","article-title":"Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury","volume":"65","author":"Menzel","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.tips.2021.11.015_bb0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2015.12.006","article-title":"Core neuropathological abnormalities in progranulin-deficient mice are penetrant on multiple genetic backgrounds","volume":"315","author":"Petkau","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2021.11.015_bb0280","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2011.08.029","article-title":"Core features of frontotemporal dementia recapitulated in progranulin knockout mice","volume":"45","author":"Ghoshal","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2021.11.015_bb0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20091568","article-title":"Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice","volume":"207","author":"Yin","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2021.11.015_bb0290","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jnnp-2019-321954","article-title":"Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia","volume":"91","author":"Heller","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tips.2021.11.015_bb0295","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.11.015_bb0300","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.celrep.2017.08.056","article-title":"Lipidomic and transcriptomic basis of lysosomal dysfunction in progranulin deficiency","volume":"20","author":"Evers","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.11.015_bb0305","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/hmg\/ddx364","article-title":"Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients","volume":"26","author":"Valdez","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2021.11.015_bb0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-020-01037-x","article-title":"Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations","volume":"8","author":"Huang","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tips.2021.11.015_bb0315","first-page":"845","article-title":"Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis","volume":"127","author":"Gotzl","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2021.11.015_bb0320","article-title":"Cathepsin D variants associated with neurodegenerative diseases show dysregulated functionality and modified alpha-synuclein degradation properties","volume":"9","author":"Bunk","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2021.11.015_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.283","article-title":"Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of alpha-synuclein aggregates","volume":"6","author":"Bae","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2021.11.015_bb0330","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo","volume":"2","author":"Cullen","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.tips.2021.11.015_bb0335","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/15548627.2019.1637200","article-title":"Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis","volume":"16","author":"Marques","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.tips.2021.11.015_bb0340","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","article-title":"Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study","volume":"19","author":"Moore","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2021.11.015_bb0345","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051668","article-title":"Progranulin and TMEM106B: when two become wan","volume":"21","author":"Clayton","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tips.2021.11.015_bb0350","first-page":"2438","article-title":"Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin","volume":"118","author":"Kessenbrock","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2021.11.015_bb0355","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0092-8674(02)01141-8","article-title":"Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair","volume":"111","author":"Zhu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.11.015_bb0360","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1002\/cne.22430","article-title":"Progranulin expression in the developing and adult murine brain","volume":"518","author":"Petkau","year":"2010","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tips.2021.11.015_bb0365","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2051-5960-1-16","article-title":"Promoter DNA methylation regulates progranulin expression and is altered in FTLD","volume":"1","author":"Banzhaf-Strathmann","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tips.2021.11.015_bb0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-020-00369-5","article-title":"Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency","volume":"15","author":"Frew","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2021.11.015_bb0375","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-021-00472-1","article-title":"Processing of progranulin into granulins involves multiple lysosomal proteases and is affected in frontotemporal lobar degeneration","volume":"16","author":"Mohan","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2021.11.015_bb0380","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0100-17.2017","article-title":"Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations","volume":"4","author":"Holler","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.tips.2021.11.015_bb0385","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bies.200900086","article-title":"The granulin gene family: from cancer to dementia","volume":"31","author":"Bateman","year":"2009","journal-title":"BioEssays"},{"key":"10.1016\/j.tips.2021.11.015_bb0390","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1021\/acs.biochem.9b00275","article-title":"Multi-granulin domain peptides bind to pro-cathepsin D and stimulate its enzymatic activity more effectively than progranulin in vitro","volume":"58","author":"Butler","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2021.11.015_bb0395","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1523\/JNEUROSCI.4808-14.2015","article-title":"The progranulin cleavage products, granulins, exacerbate TDP-43 toxicity and increase TDP-43 levels","volume":"35","author":"Salazar","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.11.015_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008295","article-title":"Age- and stress-associated C. elegans granulins impair lysosomal function and induce a compensatory HLH-30\/TFEB transcriptional response","volume":"15","author":"Butler","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tips.2021.11.015_bb0405","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.3390\/ijms19103060","article-title":"Granulin A synergizes with cisplatin to inhibit the growth of human hepatocellular carcinoma","volume":"19","author":"Qiao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2021.11.015_bb0410","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/hmg\/ddt534","article-title":"Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency","volume":"23","author":"Lee","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2021.11.015_bb0415","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ajhg.2010.11.002","article-title":"Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma","volume":"87","author":"Carrasquillo","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tips.2021.11.015_bb0420","article-title":"C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking","volume":"6","author":"Zheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.11.015_bb0425","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.neurobiolaging.2013.04.022","article-title":"The neurotrophic properties of progranulin depend on the granulin E domain but do not require sortilin binding","volume":"34","author":"De Muynck","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2021.11.015_bb0430","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1750-1326-7-33","article-title":"Progranulin regulates neuronal outgrowth independent of sortilin","volume":"7","author":"Gass","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2021.11.015_bb0435","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1002\/j.1460-2075.1993.tb06218.x","article-title":"Targeted disruption of the mouse cation-dependent mannose 6-phosphate receptor results in partial missorting of multiple lysosomal enzymes","volume":"12","author":"Ludwig","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.tips.2021.11.015_bb0440","doi-asserted-by":"crossref","first-page":"17068","DOI":"10.1523\/JNEUROSCI.4067-10.2010","article-title":"Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration","volume":"30","author":"Liu","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.11.015_bb0445","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1038\/ncomms11992","article-title":"Prosaposin is a regulator of progranulin levels and oligomerization","volume":"7","author":"Nicholson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.11.015_bb0450","doi-asserted-by":"crossref","first-page":"16101","DOI":"10.1074\/jbc.M110.193433","article-title":"Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia","volume":"286","author":"Cenik","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.11.015_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188830","article-title":"Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection","volume":"12","author":"Hammond","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.11.015_bb0460","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.cell.2021.08.002","article-title":"Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic","volume":"184","author":"Logan","year":"2021","journal-title":"Cell"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721002327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721002327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:14:22Z","timestamp":1759050862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721002327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":92,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0165614721002327"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.11.015","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progranulin as a therapeutic target in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}